Literature DB >> 9511926

Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method.

L D Selemon1, G Rajkowska, P S Goldman-Rakic.   

Abstract

Neuropsychologic testing in schizophrenic patients has underscored the prominence of dysfunction in cognitive processes associated with the dorsolateral prefrontal cortex. Quantitative cytometric analysis of area 46 was undertaken in brains from schizophrenic patients to determine whether there are morphologic changes underlying these cognitive deficits. Postmortem brain specimens from 9 schizophrenic patients, 10 normal subjects, and 8 Huntington's diseased patients were fixed in formalin and celloidin embedded. A direct, three-dimensional counting method was used to determine cell density and cortical thickness in Nissl-stained sections of area 46. Overall neuronal density was 21% greater in brains from schizophrenic patients in comparison to normal controls. Significant elevations in neuronal density were observed in layers II, III, IV, and VI. The cortical ribbon was slightly (8%) but not significantly thinner. However, layer II exhibited disproportionate thinning compared with all other layers. In brains from Huntington's diseased patients, increases in neuronal (35%) and glial (61%) density with substantial cortical thinning (30%) were observed. The neuropathology of area 46 in schizophrenia is similar in direction and magnitude to that previously described in area 9 (Selemon et al. [1995] Arch. Gen. Psychiatry 52:805-818), except for the abnormalities in layer II, which are specific to area 46. In contrast to Huntington's disease, in which cortical atrophy and gliosis are present, no evidence for cortical cell loss was uncovered in the schizophrenic cohort. The observed elevation in neuronal density suggests that a reduction in interneuronal neuropil may constitute the anatomical substrate for prefrontal cortical dysfunction in schizophrenia.

Entities:  

Mesh:

Year:  1998        PMID: 9511926

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  104 in total

1.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics.

Authors:  G J Popken; W E Bunney; S G Potkin; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 2.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

Review 3.  Insights and treatment options for psychiatric disorders guided by functional MRI.

Authors:  Tonmoy Sharma
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 4.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

5.  Follow-up MRI study of prefrontal volumes in first-episode psychotic patients.

Authors:  Chandlee C Dickey; Dean F Salisbury; Almos I Nagy; Yoshio Hirayasu; Chang Uk Lee; Robert W McCarley; Martha E Shenton
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

6.  Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease.

Authors:  Magdalena Kulijewicz-Nawrot; Alexei Verkhratsky; Alexander Chvátal; Eva Syková; José J Rodríguez
Journal:  J Anat       Date:  2012-06-27       Impact factor: 2.610

Review 7.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

8.  An in vivo MRI study of prefrontal cortical complexity in first-episode psychosis.

Authors:  Laura C Wiegand; Simon K Warfield; James J Levitt; Yoshio Hirayasu; Dean F Salisbury; Stephan Heckers; Sylvain Bouix; Daniel Schwartz; Magdalena Spencer; Chandlee C Dickey; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.

Authors:  L Fredrik Jarskog; Zhengchao Dong; Alayar Kangarlu; Tiziano Colibazzi; Ragy R Girgis; Lawrence S Kegeles; Deanna M Barch; Robert W Buchanan; John G Csernansky; Donald C Goff; Michael P Harms; Daniel C Javitt; Richard Se Keefe; Joseph P McEvoy; Robert P McMahon; Stephen R Marder; Bradley S Peterson; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2013-01-16       Impact factor: 7.853

10.  Subject-level measurement of local cortical coupling.

Authors:  Simon N Vandekar; Russell T Shinohara; Armin Raznahan; Ryan D Hopson; David R Roalf; Kosha Ruparel; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite
Journal:  Neuroimage       Date:  2016-03-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.